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Terrie E. Inder, MD; Susan E. Jacobs, MD; for the Infant Cooling Evaluation Collaboration
Objective:To investigate the effects of hypothermia treat-
ment on magnetic resonance imaging (MRI) patterns of
brain injury in newborns with hypoxic-ischemic en-
cephalopathy compared with normothermia, including
the prognostic utility of MRI for death and/or disability
at a postnatal age of 2 years.
Design: Substudy of a randomized controlled trial.
Setting:Participating centers in the InfantCoolingEvalu-
ation trial.
Participants: Trial participants (gestational age 35
weeks with moderate to severe hypoxic-ischemic
encephalopathy, randomized to whole-body hypother-
mia or normothermia) with available MRIs.
Main Exposure: We performed qualitative evaluation
of T1- and T2-weighted and diffusion MRIs. The poste-
rior limb of the internal capsule was classified as normal
or abnormal, whereas the basal ganglia and thalami, white
matter, and cortical gray matter were classified as normal
or mildly abnormal or moderately/severely abnormal.
Main Outcome Measures: Death or major disability
at 2 years.
Results:Weevaluated 127MRIs (66 patients treatedwith
hypothermia and61withnormothermia;mean age at scan,
6postnatal days).Theoddsofhavingmoderate/severewhite
matter or cortical graymatter abnormalities onT1- andT2-
weighted MRI were reduced by hypothermia (white mat-
ter odds ratio, 0.28 [95%CI, 0.09-0.82]; gray matter odds
ratio, 0.41 [0.17-1.00]). Abnormal MRI findings pre-
dicted adverse outcomes, with T1- and T2-weighted and
diffusionMRI abnormalities in the posterior limbof the in-
ternal capsule and basal ganglia and thalami demonstrat-
ing the greatest predictive value. There was little evidence
that prognostic value of the MRI was modified by thera-
peutic hypothermia (all interactions, P .05).
Conclusions: Brain injury on T1- and T2-weightedMRI
is reduced in hypothermia-treated newborns. Abnormal
MRI findings are prognostic of long-termoutcome inmod-
erate to severe hypoxic-ischemic encephalopathy regard-
less of treatment with hypothermia.
Trial Registration: anzctr.org.au Identifier:
ACTRN12606000036516
Arch Pediatr Adolesc Med. 2012;166(7):634-640
H YPOXIC-ISCHEMIC EN-cephalopathy (HIE) interm and near-term new-borns is an importantcause of morbidity and
mortality.1,2 Therapeutic hypothermia has
been a major advance in the management
of neonatal HIE. Meta-analyses of several
largemulticenter trialshave concluded that
hypothermia treatment is associatedwith a
reduction in death and neurological im-
pairment in early childhood.3-9 These re-
sults were confirmed in the recently re-
ported Infant Cooling Evaluation (ICE)
randomizedcontrolledtrial, inwhichwhole-
bodyhypothermia treatmentwas shown to
reduce death or major sensorineural dis-
ability at 2 years of age compared with
normothermia.7
Magnetic resonance imaging (MRI)
assists in defining the nature and extent
of perinatal brain injury. Because hypoxic-
ischemic (HI) cerebral injury is a dy-
namic process, the diagnostic and prog-
nostic utility ofMRIneeds to be interpreted
in the context of the timing of the MRI.
Patterns of brain injury on conventional
T1- and T2-weighted MRI at 1 week after
birth have been shown to predict abnor-
mal neuromotor outcome in early child-
hood.10Diffusion-weighted imaging (DWI)
and apparent diffusion coefficient (ADC)
changes with HI injury are most promi-
nent from days 2 through 5 and can be
detected earlier than abnormalities de-
tected on the conventional T1- and T2-
weighted MRI.11 In the Total Body Hypo-
thermia for Neonatal Encephalopathy
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(TOBY) trial, MRI studies performed a median of 8 days
after birth reported a reduction in the incidence of ce-
rebral injury compared with normothermia but consis-
tent prognostic value from MRI irrespective of treat-
ment.12 However, we need to determine whether this
prognostic utility is similar in a different cohort withMRI
performed at a different median age.
The aims of this study were to investigate (1) the
effects of hypothermia on MRI patterns of brain injury
compared with normothermia; (2) the prognostic util-
ity of MRI in moderate to severe HIE for predicting
death or major disability at 2 years; and (3) whether
this prognostic utility is affected by hypothermia treat-
ment. We hypothesized that the proportion of new-
borns with significant cerebral lesions characteristic of
HIE on MRI would be reduced in those treated with
hypothermia, that MRI would be prognostic of death
or major disability at 2 years of age, and that the prog-
nostic utility of MRI would not be altered by hypo-
thermia treatment.
METHODS
PATIENTS
This study is a substudy of the ICE trial, a multicenter, inter-
national, randomized controlled trial of moderate whole-body
hypothermia compared with standard care in newborns of at
least 35 weeks’ gestation with moderate or severe clinical en-
cephalopathy and evidence of peripartum HI (defined as 2 of
the following criteria: Apgar score 5 at 10 minutes, contin-
ued need for mechanical ventilation at 10 minutes, and meta-
bolic acidosis [cord or an arterial, venous, or capillary pH of
7.00 or base deficit12mEq/Lwithin 60minutes of birth]).7
Newborns in the ICE trial were recruited at birth from 28 cen-
ters acrossAustralia,NewZealand,Canada, and theUnited States
from February 14, 2001, through July 27, 2007, and were ran-
domized to whole-body hypothermia (target temperature,
33.5°C; range, 33°C-34°C) or normothermia (target tempera-
ture, 37°C; range, 36.8°C-37.3°C) within the first 6 hours af-
ter birth and continuing for 72 hours. This substudy includes
ICE participants who had MRIs made available for indepen-
dent assessment. The trial protocol was approved by the Hu-
man Research and Ethics committees of each of the 28 partici-
pating sites.
MRI METHODS
Participants in the ICE study underwent MRI within the first 10
days afterbirthwithconventionalT1- andT2-weightedMRI,DWI,
and ADC sequences at 1.5 T or 3.0 T according to the participat-
ing site’s clinical practice. Images made available for this sub-
study were assessed by 3 investigators experienced in neonatal
neuroimaging who were not part of the ICE trial (J.L.Y.C., L.C.,
and R.W.H.) and who were blinded to treatment allocation and
the clinical details of the participants, apart from gestational age
at birth and postnatal age at the time of MRI. Images considered
to be inadequate for analysis were excluded. Images were evalu-
ated by each investigator and results compared; any disagree-
mentwas resolved by consensus. The pattern of brain injurywas
classified according to abnormalities in brain regions known to
be susceptible in HIE, based on Rutherford et al.12 For conven-
tional T1- and T2-weighted MRIs and DWIs, the following re-
gions were systematically classified.
1. The posterior limb of the internal capsule (PLIC) was
classified as normal or abnormal, in which abnormality was de-
termined by a reduced or absent signal intensity on T1- or T2-
weighted sequences and/or by qualitatively assessed, abnor-
mally restricted or increaseddiffusiononDWI.Areas of restricted
diffusion on DWI were confirmed by areas of reduced signal
on the ADC map.
2. The basal ganglia and thalamus (BGT) were classified as
normal/mild abnormality if no or minimal focal signal abnor-
mality on T1- or T2-weighted sequences and/or normal diffu-
sion characteristics were noted and as moderate/severe abnor-
mality if multifocal or widespread abnormalities were noted on
T1- or T2-weighted signal and/or by qualitative abnormality
on DWI and ADC sequences.
3. The white matter was classified as normal/mild abnor-
mality if no or mild signal abnormality on T1- or T2-weighted
sequences and/or normal diffusion characteristics were noted.
Moderate/severe white matter abnormality was assigned if
signal abnormalities or qualitative diffusion abnormalities
(restricted ADC) extended to the subcortical white matter or
if more than 3 regions of abnormal white matter were found.
4. The cortical gray matter was classified as normal/mild ab-
normality if no or mild signal abnormality on T1- or T2-
weighted sequences or qualitative diffusion abnormalities in 2 or
fewer sites (including the central sulcus, interhemispheric fis-
sure, and insula region)werenoted.Moderate/severe cortical gray
matter abnormality referred to more extensive involvement.
Examples of the MRI classification are demonstrated in
Figures 1, 2, and 3.
NEURODEVELOPMENTAL OUTCOME
Theprimary composite outcomeof the ICE trialwas death orma-
jor sensorineural disability at 2 years of postnatal age.Major sen-
sorineural disabilitywas defined as having neuromotor delay, de-
velopmental delay, blindness (vision worse than 20/200 OU),
and/or deafness requiring amplification orworse.Neuromotor de-
laywas defined as cerebral palsy inwhich the childwas notwalk-
ing at 2 years of age, Psychomotor Development scores on the
Bayley Scales of Infant Development (BSID) II or Motor Com-
posite Scale score on the BSID III were 2 SDs or less, or disability
level on the Gross Motor Function Classification System ranged
from II to V.13,14 Developmental delay consisted of a Mental De-
velopment Index score on the BSID II or Cognitive or Language
Composite Scale scores on the BSID III of 2 SDs or less.13,15,16
STATISTICAL ANALYSIS
Data were analyzed using commercially available statistical
software (STATA, version 11.0; StataCorp). The MRI charac-
teristics were compared between the treatment groups using
separate logistic regression models for each of the T1- and T2-
weighted and diffusion variables, with results presented as odds
ratios (ORs) with 95% CIs. The MRI variables were investi-
gated as predictors of death or major sensorineural disability
at 2 years of age using logistic regression adjusted for treat-
ment group. Initially, each MRI variable was assessed as a pre-
dictor of outcome in a separate regressionmodel. In these uni-
variable models, whether the relationship between the MRI
variable and outcomewas the same in the hypothermia and stan-
dard care groups was assessed by allowing for a different effect
of the MRI variables in the 2 treatment groups (an interaction
effect). In view of the potential influence of the day of MRI on
prognostic utility, we repeated the analysis including age atMRI
as a covariate. Next, we analyzed MRI variables in a combined
model (one for conventional T1- and T2-weighted abnormali-
ties and another for diffusion abnormalities) to determine in-
ARCH PEDIATR ADOLESC MED/VOL 166 (NO. 7), JULY 2012 WWW.ARCHPEDIATRICS.COM
635
©2012 American Medical Association. All rights reserved.
Downloaded From: https://archpedi.jamanetwork.com/ by Rory  Jackson on 10/12/2015
dependent predictors of outcome. Again, results are presented
as ORs (95% CIs). Finally, we calculated the sensitivity, speci-
ficity, and positive and negative predictive values for eachMRI
variable in predicting 2-year outcomes, presentedwith 95%CIs.
RESULTS
Twohundred twenty-oneneonateswere recruited into the
ICEtrial;177underwentMRI,ofwhichimages for128were
madeavailableforindependentassessmentforthissubstudy,
including 127 images suitable for T1- and T2-weighted
analysis and 126 for DWI and ADC analyses. No congen-
ital brain malformations were noted on MRI in any of the
participants.Baselinecharacteristicsweresimilar forthepar-
ticipants in this substudycomparedwithparticipants in the
ICE study without MRIs available (results not shown).
Table1 summarizes the patient characteristics of this
substudy. Sixty-six newborns underwent treatment with
hypothermia and 61 with normothermia. All baseline
characteristics were similar between the groups in this
substudy. The differences inmortality and the 2-year out-
come of death ormajor disability between the groupswere
not statistically significant in this substudy, in contrast
to the results for the study overall.
Table 2 summarizes the MRI abnormalities present
by treatment group. Fewer newborns had moderate/
severe white matter and cortical gray matter abnormali-
ties on T1- and T2-weighted MRI in the hypothermia-
treated comparedwith thenormothermia-treatednewborns
(OR forwhitematter, 0.28 [95%CI, 0.09-0.82];OR for gray
matter, 0.41 [0.17-1.00]). Although fewer abnormalities
of the PLIC were detected on T1- and T2-weighted MRI
in the hypothermia-treated group, this difference did not
A B C D
Figure 1. Appearance of hypoxic-ischemic encephalopathy on T2-weighted axial magnetic resonance imaging. A, A normal brain in a term newborn with
myelination in the posterior limb of the internal capsule (PLIC). B, Severely abnormal basal ganglia and thalamus (BGT) lesions, absent myelination of the PLIC,
and abnormal signal in the white matter, especially in the frontal lobes. C, Moderately abnormal BGT involving the putamen and thalamus, with myelination of the
PLIC present. D, Abnormal signal in the Rolandic cortex.
A B C
Figure 2. Appearance of hypoxic-ischemic encephalopathy on T1-weighted axial magnetic resonance imaging. A, A normal brain in a term newborn. B, Severely
abnormal basal ganglia and thalami (BGT), absent myelination in the posterior limb of the internal capsule (PLIC), and widespread abnormal cortical gray matter.
C, Moderately abnormal BGT signal involving the putamen and thalamus, with myelination of the PLIC present.
A B C
Figure 3. Appearance of hypoxic-ischemic encephalopathy on axial
diffusion-weighted magnetic resonance imaging. A, A normal brain in a term
newborn with no areas of restricted diffusion. B, Severely restricted diffusion in
the basal ganglia and thalami, posterior limb of the internal capsule, and white
matter. C, Focal restricted diffusion in the putamen and optic radiations.
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reach statistical significance. We found a trend to reduc-
tion indiffusionabnormalities in thePLIC,BGT,whitemat-
ter, and cortical gray matter in newborns treated with hy-
pothermiacomparedwithnormothermia,but thisdifference
also did not reach statistical significance.
All T1- and T2-weighted and diffusion MRI abnor-
malities were predictive of death or major sensorineural
disability at 2 years of age (Table 3). There was little
evidence of an interaction between hypothermia treat-
ment and the prognostic utility of any of the MRI vari-
ables (all interaction, P  .05, where calculable). When
age at MRI was included as a covariate, the prognostic
utility of all T1- and T2-weighted and diffusion abnor-
malities remained unchanged (data not shown). Com-
bining predictors into a single model for T1- and T2-
weighted imaging found abnormal PLIC (OR, 4.10 [95%
CI, 1.13-14.84; P = .03]) and moderate/severe BGT ab-
normalities (OR, 10.09 [3.19-31.85; P  .001]) were in-
dependent predictors of 2-year outcome. Similarly, ab-
normal PLIC (OR, 4.81 [95% CI, 1.40-16.60; P = .01])
andmoderate/severe BGT abnormalities (OR, 9.38 [ 2.88-
30.55;P .001]) ondiffusionMRIwere independent pre-
dictors of 2-year outcome.
All T1- and T2-weighted and diffusion abnormalities
had high sensitivity and negative predictive values as pre-
dictors for adverse outcome at 2 years of age (Table 4).
Moderate to severe BGT abnormalities had the highest
combined sensitivity and specificity (and positive and
negative predictive values) for adverse outcome at 2 years
for T1- and T2-weighted images and DWI.
COMMENT
The results from this substudy of a large, multicenter,
randomized controlled trial of whole-body hypother-
mia in neonates with HIE demonstrate that brain injury
in the white matter and cortical gray matter, identified
on conventional T1- and T2-weighted MRI, was re-
duced in newborns who received hypothermia treat-
ment compared with those who received normothermia
treatment.We also found a trend toward reduced abnor-
malities in the PLIC in hypothermia-treated newborns,
although with little evidence of an effect of therapeutic
hypothermia on injury within the BGT.
A reduction in the extent of brain injury on conven-
tional T1- and T2-weightedMRIwith hypothermia treat-
ment has been previously described,12,17,18 although find-
ings regarding the regions of the brain protected by
hypothermia treatment have varied. One study reported
a reduction in BGT lesions,17 whereas another reported
a reduction in cortical graymatter abnormalities.18 Amore
recent report from the TOBY trial found that hypother-
mia treatment was associated with a reduction in abnor-
malities in several brain regions, including the BGT, PLIC,
and white matter.12 In the present study, the proportion
of newborns withmoderate/severe white matter and cor-
tical graymatter abnormalities on conventional MRI was
reduced with hypothermia treatment, with a trend for a
reduction in PLIC abnormalities. However, we found little
evidence of a difference in BGT abnormalities between
the groups. Lesions of the BGT have been recently re-
ported to be strongly associated withmotor outcomes in
early childhood.10 The TOBY trial found a reduction in
cerebral palsy in newborns who received hypothermia,4
but this was not seen in the ICE trial; instead, mortality
and the combined outcome of death or major disability
were reduced, but the rate of cerebral palsy was similar
between groups.7 Moreover, the 2-year outcomes in this
substudy were similar in neonates treated with hypo-
thermia compared with those allocated to normother-
mia. The difference inmotor outcomes between the TOBY
and ICE randomized trials may explain why a reduction
inMRI brain abnormalities was seen in different regions
in the hypothermia- compared with normothermia-
treated groups. These differences in neurological out-
comes and underlying patterns of brain injury may also
reflect the difference in the nature of the recruited popu-
lation, in particular, variation in the inclusion criteria.
In addition, other factors, including the different MR se-
Table 1. Participant Characteristicsa
Characteristic
Treatment Groups
P
Valueb
Hypothermia
(n = 66)
Normothermia
(n = 61)
Male sex, No. (%) 35 (53) 38 (62) .29
Gestational age, wk 38.9 (1.8) 38.9 (1.6) .85
Birth weight, g 3318 (635) 3489 (597) .12
10-min Apgar score,
median (IQR)c
4.0 (2.5-5.0) 4.0 (3.0-5.0) .57d
Severity of
encephalopathy
at assessment
of eligibility
for the ICE trial,
No. (%)e
Moderate 39 (59) 31 (51)
.77
Severe 14 (21) 14 (23)
Cord or blood gas pH
within 1 h of birthf
6.9 (0.2) 6.9 (0.2) .82
Base excess, mEq/Lg −20.8 (7.9) −19.2 (9.6) .36
Clinical seizures, No. (%) 49 (74) 48 (79) .35
Age at randomization, h 4.0 (1.3) 3.9 (1.2) .53
Time of MRI,
median (IQR),
postnatal d
6 (3-7) 6 (4-8) .89
Death, No. (%)
For this substudy 14/66 (21) 17/61 (28) .38
For the ICE trial 27/108 (25) 42/109 (39) .03
Death or major
disability at age 2 y,
No./Total No. (%)h
For this substudy 30/65 (46) 33/57 (58) .20
For the ICE trial 55/107 (51) 67/101 (66) .03
Abbreviations: ICE, Infant Cooling Evaluation; IQR, interquartile
range; MRI, magnetic resonance imaging.
aUnless otherwise indicated, data are expressed as mean (SD).
bCalculated from t tests for continuous variables and 2 tests
for categorical variables.
cData were unavailable for 4 participants.
dCalculated from a Wilcoxon rank sum test.
eData were unavailable for 1 participant in the normothermia group.
fData were unavailable for 2 participants in the hypothermia group
and 13 in the normothermia group.
gData were unavailable for 13 participants in the hypothermia group
and 17 in the normothermia group.
hData were missing for 5 participants of this substudy and 9 in the
ICE study.
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quences used and the timing of MRI, may account for
the different findings in the present study and the TOBY
study. Themedian age at the timeof imaging in the present
study was 6 days, which is earlier than that in the pre-
vious report from the TOBY substudy (median age at the
time of the scan, 8 days).12 Nonetheless, reductions in
injury in brain regions reported in both MRI studies are
similar to those reported in experimental models of peri-
natal HI. Reduction in histologic injury in the cortex, deep
graymatter, hippocampus, brainstem, and cerebellumhas
been previously described in rodents, piglets, and
sheep.19-21
Abnormalities of the BGT and PLIC on conventional
MRI have been shown to be strongly correlated in pre-
vious studies, most of which have had the MRIs per-
formed after the first postnatal week.10,12 In the group of
newborns in our substudy with the combination of mod-
erate/severe BGT abnormalities and a normal PLIC, the
median timing ofMRI was 4 days after birth. Because the
cerebral abnormalities after HIE are evolving during this
early period, the BGT may have been established before
the PLIC abnormalities became apparent. This finding
may have been exaggerated in the hypothermia-treated
group because of the temporal effects of evolution ofMRI
cerebral abnormalities related to hypothermia.
In the present study, we found that moderate to se-
vere brain lesions in the PLIC, BGT, white matter, and
cortical gray matter on conventional T1- and T2-
weighted and diffusion MRI were all prognostic of poor
outcome at 2 years of age. Moreover, there was little evi-
dence that the prognostic utility of MRI was altered by
hypothermia treatment. This finding is important for cli-
nicians because hypothermia is nowwidely used to treat
moderate to severe HIE. Of the MR lesions considered,
abnormalities of the PLIC and BGT on conventional and
diffusion MRI were independent predictors of death or
major disability at 2 years of age, with sensitivities in the
range of 87% to 89% and high negative predictive val-
ues of approximately 93%. As alluded to earlier, given
the conspicuity and timing of diffusion changes in the
brain after HIE, significant reliance is placed on this se-
quence for clinical interpretation in the first week after
birth. Thus, the finding that diffusion abnormalities on
MRI at the end of the first week after birth are predictive
Table 2. MRI Abnormalities in Hypothermia-Treated Group vs Normothermia-Treated Group
Treatment Group, No. (%) of Participants
OR (95% CI)a P Valuea
Hypothermia
(n = 66)
Normothermia
(n = 61)
T1- and T2-weighted abnormalities (n = 127)
PLIC score 14 (21) 22 (36) 0.48 (0.22-1.05) .07
Moderate/severe in BGT 23 (35) 22 (36) 0.95 (0.46-1.96) .89
Moderate/severe in white matter 5 (8) 14 (23) 0.28 (0.09-0.82) .02
Moderate/severe in cortical gray matter 9 (14) 17 (28) 0.41 (0.17-1.00) .05
Diffusion abnormalities (n = 126)
PLIC score 13 (20) 18 (30) 0.60 (0.26-1.36) .22
Moderate/severe in BGT 17 (26) 20 (33) 0.73 (0.34-1.57) .42
Moderate/severe in white matter 7 (11) 13 (21) 0.45 (0.16-1.21) .11
Moderate/severe in cortical gray matter 10 (15) 16 (26) 0.51 (0.21-1.24) .14
Abbreviations: BGT, basal ganglia and thalami; MRI, magnetic resonance imaging; OR, odds ratio; PLIC, posterior limb of the internal capsule.
aCalculated from separate logistic regression models for T1- and T2-weighted and diffusion variables with treatment group as a predictor.
Table 3. MRI Characteristics as Predictors of Death or Major Disability at Age 2 Years
Death/Disability
at Age 2 y, No. (%)
OR (95% CI)a P Value
P Value
for Interactionb
Normal
MRI Score
Abnormal
MRI Score
T1- and T2-weighted abnormalities (n = 122)
PLIC score 33/88 (38) 30/34 (88) 12.08 (3.89-37.52) .001 .33
BGT score 25/79 (32) 38/43 (88) 17.56 (6.05-51.02) .001 .50
White matter score 47/103 (46) 16/19 (84) 5.92 (1.59-21.96) .008 NA
Cortical gray matter score 40/96 (42) 23/26 (88) 10.27 (2.86-36.91) .001 .83
Diffusion abnormalities (n = 121)
PLIC score 36/91 (40) 26/30 (87) 9.62 (3.09-29.97) .001 NA
BGT score 30/85 (35) 32/36 (89) 14.54 (4.67-45.25) .001 .42
White matter score 45/101 (45) 17/20 (85) 6.62 (1.81-2419) .004 NA
Cortical gray matter score 39/95 (41) 23/26 (88) 10.50 (2.83-37.55) .001 NA
Abbreviations: BGT, basal ganglia and thalami; MRI, magnetic resonance imaging; NA, not available; OR, odds ratio; PLIC, posterior limb of the internal
capsule.
aResults from separate regression models for death/disability for each T1- and T2-weighted and diffusion predictor adjusted for treatment group.
bA number of the interactions were not available because of a zero cell in the cross-tabulation of the predictor and outcome within one or both of the
treatment groups.
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of death or significant sensorineural disability at 2 years
is of clinical and practical importance.
Concerns have been raised about the possibility of hy-
pothermia treatment affecting the time course of lesion
evolution on MRI, especially with diffusion restriction.
Given that hypothermia seems to affect lesion evolu-
tion, this findingmay have potential implications on the
optimal timing of MRI for prognostic purposes. Previ-
ous recommendations are that MRI be performed at the
end of the first postnatal week when acute changes have
occurred but before the evolution of brain atrophy22,23;
another study reported that MRIs performed at a me-
dian of 8 days were prognostic of outcome.12 Although
the present study could not address the question of op-
timal timing ofMRI for prognostication in hypothermia-
treated newborns with HIE, we demonstrated that MRIs
performed at a median age of 6 days are prognostic of
death or major sensorineural disability at 2 years. When
age at MRI was included as a covariate in our analysis,
the prognostic utility of conventional and diffusionMRI
remained unaltered.
This study has several strengths. The sample size is
relatively large and constitutes a representative sub-
group of a large,multicenter, randomized controlled trial;
therefore, the results are likely to be applicable to many
tertiary neonatal centers that administer hypothermia
treatment to term newborns with HIE. The MRI classi-
fication system used is simple, has a high interrater re-
liability,12 and can be practically used in the clinical set-
ting. However, for individualized and more refined
prognostication of outcome, a more detailed MRI ap-
praisal of abnormalities may be required. In addition, we
have reported on MRI abnormalities and the prognostic
utility of diffusion imaging, a widely used sequence in
newborn HIE neuroimaging protocols.
However, we also acknowledge some limitations. Not
all newborns in the ICE trial underwent MRI, and not all
MRIs were made available for this substudy, although the
clinical characteristicsof thenewborns in this substudywere
similar to those of participants in the larger ICE trial. Be-
cause higher rates of deathwere found in the ICE trial com-
pared with this substudy, the most severely affected neo-
natesmaynothavehadMRIexaminationsperformedbefore
redirection to palliative care,whichwouldhave been in the
first few days after birth. Therewere also variationswithin
the sequence protocol between centerswithin the ICE trial,
whichmay have affected the interpretation ofmore subtle
changes in the MRIs.
In summary, the reduction in brain injury in the hypo-
thermia-treated group comparedwith the normothermia-
treated group found in this study further supports hypo-
thermia as a treatment formoderate to severeHIE in terms
of reducing the incidence of white and cortical gray mat-
ter abnormality. Moreover, these results have shown that
conventional and diffusion MRI of the brain are impor-
tant biomarkers of long-term outcome in newborns with
HIE, with or without hypothermia treatment.
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